Russia open to Trump-Putin call as plague lab death raises bioweapon concerns

A 28-year-old researcher at a Siberian laboratory died on October 2nd, and within days the death had become a matter of international concern, diplomatic conversation, and biosecurity alarm. Darya Shipilova worked at the Irkutsk Anti-Plague Institute, a research facility more than 2,500 miles east of Moscow. Russian authorities initially offered only a vague diagnosis: pneumonia of unknown origin. But early reports from independent Russian media suggested something more specific and far more troubling—that she had contracted pneumonic plague after a laboratory accident and died from the disease itself.

The ambiguity triggered immediate action at the highest levels. President Trump told reporters on Tuesday night that he expected to speak with Vladimir Putin "very soon" about the death. Secretary of State Marco Rubio called on Russia to be more transparent and to share information with the world. The State Department formally engaged Russian authorities through the embassy in Moscow, requesting additional details and urging Russia to provide them quickly and openly. Russia's government responded Wednesday by saying it was open to scheduling a phone call between the two presidents promptly, though nothing had been confirmed yet.

Russian health authorities moved to contain the situation and, they claimed, to contain any risk. The national health watchdog, Rospotrebnadzor, said it had screened 200 people who had come into contact with Shipilova. None of them tested positive for plague or other dangerous pathogens. The agency conducted nearly 5,000 laboratory tests across those individuals. About 90 percent of the 200 who had been placed under quarantine conditions for monitoring were released. Rospotrebnadzor also noted that Shipilova had been vaccinated against the dangerous infections she worked with, meaning she should have had immunity. The agency eased precautionary measures in the Irkutsk region, saying there was no risk of an epidemic.

But the lack of a clear, definitive explanation left room for concern and speculation. The Irkutsk Anti-Plague Institute is not a simple research center. According to its own website, its work extends beyond studying the plague bacterium—which naturally occurs in animal populations across the region and elsewhere in the world—to include planning and preparation for incidents involving what it calls "potential agents of bioterrorism." In other words, the facility is part of Russia's biodefense infrastructure. Recent reports in Chinese and Western media noted that the lab's director has visited U.S. research facilities and has collaborated with Chinese authorities, including participation in a joint emergency drill in August to practice response to a theoretical cross-border infectious disease outbreak.

Annie Jacobsen, an American journalist and author of a novel about a genetically modified pneumonic plague accidentally released from a Siberian laboratory—published just months before Shipilova's death—told CBS News that the scenario represents what military experts fear most. "When it comes to the accidental release of a genetically modified pathogen from a high or maximum containment laboratory around the world," she said, "the number-one worry is Russia." She noted that during the 1980s and earlier, Russia operated a substantial illegal biological weapons program. The Irkutsk facility, she explained, was a dual-use installation: it conducted legitimate medical research against dangerous pathogens, but it also served as cover for biological weapons work. The scrutiny now focused on the lab stems not only from reports of Shipilova's possible plague infection but also from the quarantine of roughly 200 people under what Jacobsen described as "draconian measures." The real indicator of a serious problem, she said, would be any confirmed secondary infections—cases of plague or other illness in people who had contact with Shipilova.

The World Health Organization requested more information from Russia on Wednesday after some media reports suggested a possible second infection in the area. Nothing has been confirmed. Independent Russian news outlets like Lyudi Baikala, which first reported Shipilova's death and the possibility of plague, quoted a colleague saying her illness began with cold symptoms before deteriorating rapidly. After hospitalization, the roughly 200 colleagues at the institute were quarantined for three days and tested twice daily before release. Residents of Shipilova's apartment building told Russian media that a van arrived the night she died, carrying people in gas masks and orange protective suits who sprayed the building's entrance with what residents believed was disinfectant.

Reporters from the French news agency AFP who visited Irkutsk on Tuesday found residents going about their daily lives. Those willing to speak said they were not worried, citing official assurances that no confirmed cases had emerged and that people who had contact with infected individuals had been isolated without incident. But tight government control over information in Russia makes independent verification difficult. And despite Moscow's reassurances, neighboring countries were taking their own precautions. As of Wednesday, Kazakhstan, Kyrgyzstan, and Uzbekistan had all implemented additional precautionary measures at their borders with Russia to guard against possible disease spread. Until Russia provides a definitive answer about what killed Shipilova, the questions—and the regional anxiety—are likely to persist.